The Centers for Disease Control and Prevention last week recommended Pfizer’s updated COVID-19 vaccine booster for Americans aged 12 and older and Moderna’s updated COVID-19 vaccine booster for Americans aged 18 and older, as recommended by its vaccine advisory committee. Authorized by the Food and Drug Administration Aug. 31, the updated boosters are bivalent, meaning they help protect against the most recently circulating omicron variants as well as the original virus strain.  

“This recommendation followed a comprehensive scientific evaluation and robust scientific discussion,” said CDC Director Rochelle Walensky, M.D. “If you are eligible, there is no bad time to get your COVID-19 booster and I strongly encourage you to receive it.”

Related News Articles

Headline
In these video snippets from an AHA Advancing Health podcast series, health care leaders and clinicians from four children's hospitals share how they worked to…
Headline
Most health insurers must cover the updated COVID-19 vaccines from Pfizer and Moderna without cost sharing effective Sept. 11, when the Food and Drug…
Headline
The Department of Health and Human Services’ Administration for Strategic Preparedness and Response yesterday awarded $600 million for 12 domestic COVID-19…
Headline
AHA today participated in a Centers for Disease Control and Prevention Fall Immunization Kick-off Event for partner organizations, which focused on vaccinating…
Headline
AHA is providing its latest social media toolkit to help hospitals encourage vaccination against COVID-19. The newest toolkit includes messages and assets…
Headline
The Food and Drug Administration’s independent Nonprescription Drugs Advisory Committee Sept. 12 by unanimous vote declared oral phenylephrine…